| Speaker |
Title & Time |
Silvia Blemker, PhD
Professor, Biomedical Engineering, University of Virginia / CSO and Co-Founder, Springbok Analytics CSO |
Machine learning models of MRI in FSHD, predicting progression
1:00pm-1:15pm |
Doris Leung, MD PhD
Director, Center for Geneic Muscle Disorders Kennedy Krieger Institute and Associate Professor in the Department of Neurology, Johns Hopkins University |
Individual muscle metrics and function in FSHD
1:15pm-1:30pm |
Lara Riem, PhD
Director of AI and Data Science Springbok Analytics |
Patterns of fat involvement in FSHD: Strategies for assessment
1:30pm-1:45pm |
Seth Friedman, PhD
Manager of Innovation Imaging and Simulation Modeling, Seattle Children’s Hospital, Seattle, WA |
Update on DUX4 and MRI relationships, Atlas expansion (pigs)
1:45pm-2:00pm |
| Break |
2:00pm-2:15pm |
Stephen Tapscott, MD PhD
Professor, Human Biology Division, Clinical Research Division; Fred Hutchinson Cancer Research Center; Dept of Neurology, University of Washington, WA |
Molecular biomarkers and MRI: planning for clinical trials
2:15pm-2:30pm |
Leo Wang, MD PhD
Associate Professor of Neurology, University of Washington |
Muscle biomarkers as trial reporters
2:30pm-2:45pm |
Glenn Walter, PhD
Professor and Vice-Chair, Department of Physiology and Aging, University of Florida
Krista Vandenborne, PhD
Chair, Department of Physical Therapy, University of Florida |
Biomarkers and trial paths in DMD, what is working?
2:45pm-3:05pm |
Jeffrey Statland, MD
Professor of Neurology; University of Kansas Medical Center, Kansas City, KS |
Imaging trial biomarkers in FSHD, where do we go from here?
3:05pm-3:20pm |
Panel Discussion
FSHD experts from academia and industry |
Moderated panel discussion: Questions from patients, family and friends
3:20pm-4:00pm |
